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ABSTRACT Vibrio cholerae, a Gram-negative facultative pathogen, is the etiologic agent for the diarrheal disease cholera. We pre-
viouslycharacterizedaclinicalisolate,AM-19226,thattranslocatesatypeIIIsecretionsystem(T3SS)effectorproteinwithactin-
nucleatingactivity,VopF,intothehostcells.Fromcomparativegenomicstudies,weidentiﬁedadivergentT3SSislandinaddi-
tionalisolateswhichpossessaVopFhomolog,VopN.UnliketheVopF-mediatedprotrusionformation,VopNlocalizestostress
ﬁber in host cells similarly to VopL, which is present in the pandemic strain of Vibrio parahaemolyticus. Chimera and yeast two-
hybridstudiesindicatedthattheamino-terminalregionsofVopFandVopNproteinsinteractwithdistincthostcellfactors.We
determinedthatAM-19226-infectedcellsarearrestedatSphaseofthecellcycleandthatVopF/VopNareantiapoptoticfactors.
To understand how VopF may contribute to the pathogenesis of AM-19226, we examined the effect of VopF in an in vitro
polarized-epithelial model and an in vivo adult rabbit diarrheal model. Within the T3SS pathogenicity island is VopE, a ho-
mologofYopEfromYersinia,whichhasbeenshowntoloosentightjunctions.Inpolarizedintestinalepithelia,VopFandVopE
compromisedtheintegrityoftightjunctionsbyinducingcorticalactindepolymerizationandaberrantlocalizationofthetight-
junctionproteinZO-1.Anassayforpathogenicityintheadultrabbitdiarrheamodelsuggestedthattheseeffectorsareinvolved
inelicitingthediarrhealresponseininfectedrabbits.
IMPORTANCE Vibrio cholerae is a bacterial pathogen that causes the diarrheal disease cholera, which remains a major public
health problem in many developing countries. While the major virulence factors of the pandemic V. cholerae strains have been
characterized, new clinical strains of V. cholerae have arisen, causing sporadic cholera-like diseases using unknown pathogenic
mechanisms.Previously,wediscoveredthetypeIIIsecretionsysteminanewclinicalstrainof V.choleraeandalsoidentiﬁedan
effectorprotein,VopF,whichisinjectedintothehostcellsandinduceschangesintheactincytoskeleton.Inthiswork,weidenti-
ﬁedahomologofVopFthatcausesadistinctcellularphenotypeandinteractionsbetweentheeffectorsandhostproteins.We
alsodiscoveredthatbotheffectorspreventbacterium-inducedcelldeathininfectedcells.Inourtissuecultureandanimalmod-
els,weshowedthatVopFcontributestothedisruptionofepithelialintegrityandthediarrhealresponse.
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Vibriocholerae,aGram-negativefacultativepathogen,isthecaus-
ative agent for the diarrheal disease cholera. With more than 200
serogroups, this diverse organism has been able to persist in the
aquatic environment while a subpopulation has evolved to cause
human disease. The O1 and O139 serogroups have caused epi-
demics and pandemics using toxin-coregulated pilus (TCP) and
choleratoxin(CT).Whilenon-O1,non-O139strainshavecaused
sporadic disease globally (1–9), the virulence mechanisms are not
fully understood, since most of these strains lack TCP and CT.
Previously, we identiﬁed a type III secretion system (T3SS) in a
clinical non-O1, non-O139 strain, AM-19226 (10). Furthermore, a
functionalT3SSwasrequiredforcolonizationofthesmallintestinein
the infant mouse model (11). A type III effector, vopF, contains one
FH1-like domain and three WH2 domains and was characterized as
an actin nucleator. Delivery of VopF by infection or transfection in-
duces actin-rich-protrusion formation in host cells (11). Recently,
T3SS non-O1, non-O139 strains have been isolated in clinical sur-
veysandepidemiologystudiesofacutediarrhealdiseases(12).Addi-
tionally, non-O1, non-O139 strains clearly contribute genetically to
newlyemergingvariantsofV.cholerae,asexempliﬁedbyahorizontal
gene transfer event between non-O1 and O1 strains resulting in the
evolution of epidemic O139 strains (13, 14). Therefore, it is impor-
tanttomonitorandunderstandthepathogenicmechanismsofnon-
O1, non-O139 strains.
FromtheVibriogenomeproject,twoV.choleraegenomesbelong-
ing to the O1 serogroup (N16961 and O395) have been completely
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8-fold coverage. We have identiﬁed a divergent T3SS island in two
non-O1, non-O139 strains, 1587 and 623-39. 1587 is a clinical
V. cholerae strain isolated from an outbreak of cholera-like illness in
Lima, Peru (2); 623-39 is a diarrheal-disease clinical isolate from
Dhaka, Bangladesh (S. M. Faruque, unpublished data). Within the
divergent T3SS island, we have identiﬁed a vopF homolog, which we
named vopN. Interestingly, VopN localizes to the host stress ﬁbers
similarly to VopL, a VopF ortholog in Vibrio parahaemolyticus (15).
WhileVopFandVopNhavecomparableactinnucleationactivitiesin
vitro, we determined through the use of chimera studies that the re-
gionpriortotheFH1-likedomaincontainedtheinformationneces-
saryfordistinctlocalizationofthetwohomologousproteins.Ayeast
two-hybrid screen identiﬁed the distinct interacting host proteins of
VopNandVopF.Furthermore,itledustodiscoverthatbothproteins
have protective effects against apoptosis. Finally, using our in vitro
andinvivomodels,weidentiﬁedthatbothVopEandVopFtogether
are responsible for disrupting cell polarity and loosening tight junc-
tionsintheT84tissueculturemodelaswellasthediarrhealresponse
in the removable intestinal tie-adult rabbit diarrhea (RITARD)
model.
RESULTS
Identiﬁcation of a divergent T3SS pathogenicity island. Vibrio
cholerae is a diverse organism that persists in the aquatic environ-
ment.Whilemostnon-O1,non-O139strainsthriveexclusivelyin
the environment, some have evolved pathogenic mechanisms to
causehumandiseaseindependentofTCPandCT.Examinationof
thesequencingdataofeightnon-O1,non-O139V.choleraestrains
led to the discovery of a divergent T3SS island in strains 1587 and
623-39. The sequence homologies of the structural components
between the T3SS pathogenicity islands in AM-19226 and 1587
arebetween63.5%and75.1%attheDNAsequencelevel(datanot
shown). The proteins are much more homologous (between 67
and 89.6% identity and 83.8 and 96.2% similarity) (data not
shown). Due to the divergence between the nucleic acid se-
quences, this T3SS island was previously undetected by PCR,
Southern hybridization, or genomic microarray using sequences
from the AM-19226 T3SS island. Comparing the organization of
theT3SSpathogenicityislandsbetweenV.choleraeAM-19226and
1587 and V. parahaemolyticus T3SS2 (see Fig. S1 and S2 and Ta-
ble S1 in the supplemental material), we have identiﬁed a central
conserved region in which most of the structural components
reside and two peripheral variable regions where the most diver-
sityoccursand,coincidentally,wheretheputativeeffectorsreside.
TheT3SSpathogenicityislandidentiﬁedin1587and623-39con-
tains a divergent vopF homolog, which we named vopN (37%
identity and 55% similarity at the amino acid sequence level).
Amino acid sequence alignment between VopF and VopN from
V.choleraeandVopLfromV.parahaemolyticus(Fig.S3)indicated
that VopN shares characteristics with both VopF and VopL.
VopN is an actin nucleator that localizes to the stress ﬁbers.
TheVopForthologinV.parahaemolyticus,VopL,hasbeenshown
to nucleate actin in vitro while forming stress ﬁbers in infected or
transfected cells (15). To determine whether VopN induces pro-
trusion formation like VopF or stress ﬁber formation like VopL,
we transfected CHO cells with a vopN::gfp fusion construct. Actin
was visualized in ﬁxed cells by staining with Alexa Fluor 588-
conjugatedphalloidin,andweobservedthatVopN-greenﬂuores-
cent protein (GFP) localized to actin stress ﬁbers (Fig. 1A).
Togainbetterinsightintothenatureofthecellularstructuresthat
VopN and VopF induce in host cells, we conducted immunogold
electron microscopy. Anti-GFP antibodies and 10-nm gold particle-
conjugated antibodies were used to label VopF-GFP or VopN-GFP.
vopF::gfp-transfected cells showed gold labeling enrichment along
unbranched actin-rich protrusions. vopN::gfp-transfected cells, on
theotherhand,showedgoldlabelingenrichmentalongbundledactin
cables at the cell dorsal surface (Fig. 1B). To conﬁrm that VopN can
nucleate actin in vitro, we determined the activity of VopN in the
pyrene actin assay. Fast-performance liquid chromatography
(FPLC)-puriﬁed VopN-His6 protein has actin nucleation and poly-
merization activity in vitro similar to that of VopF (Fig. 1C).
Chimera studies for determining the domain required for
inducing different cellular phenotypes. The discovery of VopF
andVopNpresentsaninterestingcell-biologicalquestionofhowtwo
homologousproteinsarelocalizedtodifferentcellularstructures.We
constructed VopN/VopF hybrids in which we fused the amino-
terminalhalfofVopForVopNtothecarboxy-terminalhalfofVopN
orVopF,respectively.Transfectionexperimentswiththehybridpro-
teins showed that VopF/N are enriched at protrusions similarly to
VopF-transfected cells while the VopN/F hybrid protein localizes to
stressﬁbersimilarlytoVopN-transfectedcells(Fig.2A).Theseresults
suggestthattheamino-terminalhalvesofthesetypeIIIeffectorsplay
animportantroleindeterminingproteinsubcellularlocalization.To
systematicallynarrowdownthedomainorregionrequiredforstress
ﬁberorprotrusionlocalization,weconductedchimerastudieswhere
we fused different fragments of VopN/F to the remaining corre-
spondingfragmentsofVopF/N.Transfectionofthesegfpfusioncon-
structsledustoconcludethatnoneoftheactin-modulatingdomains
(theFH1-likedomainandthreeWH2domains)containinformation
todifferentiatethepropertiesofthetwoproteins.Rather,theregions
priortotheFH1-likedomainsaresufﬁcienttodeterminethedistinct
cellular structure localization in host cells (Fig. 2B). To conﬁrm that
amino-terminal amino acids (aa) 1 to 84 of VopN and 1 to 135 of
VopF are sufﬁcient to differentiate the proteins from each other, we
fusedthosefragmentsdirectlytoGFPanddeterminedtheirlocaliza-
tionintransfectedcells.WhileVopF1-135-GFPshoweduniformlydis-
tributed punctate localization across the cells, VopN1-84-GFP local-
ized to the actin stress ﬁbers (Fig. 2C).
VopF and VopN interact with different host proteins. The
distinctlocalizationpatternsofVopFandVopNledustohypothesize
that the two proteins interact with different host proteins. We con-
ductedayeasttwo-hybridscreenusingaHeLacellcDNAlibraryand
determined that VopN interacts with ﬁlamin A and ﬁlamin B
(Fig.3A).Filaminisafamilyofactinbindingproteinsthatcross-link
actinandlocalizetothestressﬁberintissueculturecells.Additionally,
ﬁlaminactsasascaffoldingproteinforsignalingproteinsandbridges
transmembraneproteinstotheactincytoskeleton(16).Examination
oftheVopNtruncationsindicatedthattheportioncomprisingaa1to
84 of the VopN protein could still interact with ﬁlamin while the
portioncomprisingaa1to50oftheVopNproteincouldnot(Fig.3A
anddatanotshown).Thesedatawerefurthercorroboratedbytrans-
fection and colocalization experiments with ﬁlamin (Fig. 3D). Con-
ductingtheyeasttwo-hybridscreenusingfull-lengthvopFasthebait
resulted in no signiﬁcant hits other than actin. As expected, full-
length vopF and vopN interacted with actin while the truncated fu-
sions that did not contain any actin-modulating domains did not.
Whenweconductedtheyeasttwo-hybridscreenusingthetruncated
vopF gene encoding the ﬁrst 135 aa (without the actin-modulating
domains),wediscoveredinteractionswiththecyclophilinG(PPIG),
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lism (Murr1) domain-containing 1 (COMMD1) proteins (Fig. 3A).
Interactions between the bacterial effectors and the host proteins
were conﬁrmed using coimmunoprecipitation (Fig. 3B). PPIG is a
nuclear protein that is cell cycle regulated (17). It demonstrates dis-
tinct nuclear/cytoplasmic distribution patterns during the cell cycle
(17). BCA3 and COMMD1 have been shown to repress NF-B-
dependent transcription (18, 19), and
COMMD1furtheracceleratestheubiquiti-
nation and degradation of NF-B subunits
(20).Indeed,VopFandaa1to135ofVopF,
but not VopN, had the activity to inhibit
tumor necrosis factor alpha (TNF-)-
induced NF-B activation (Fig. 3C), sug-
gesting that the binding of VopF to these
nuclearproteinsinthecytoplasmcouldex-
clude them from the nucleus and deregu-
late NF-B activity and NF-B-regulated
normalcellfunctions,suchascellcycleand
cell death (21, 22).
AM-19226 affects cell cycle progres-
sion in vitro. To investigate whether AM-
19226 affects host cell responses and
whether VopF plays a role in this context,
we infected HeLa cells with V. cholerae for
4handthenincubatedthecellsinmedium
with gentamicin for 72 h to assess the con-
tribution of translocated effectors alone.
We stained the ﬁxed cells with propidium
iodide (PI) to determine the cell cycle dis-
tributionofthesecells(Fig.4).Whileunin-
fected cells and type III mutant-infected
cells have a normal cell cycle distribution,
with the majority of cells in G1 phase, cells
infected with VTV18 (AM-19226endo
rtx hly hap) (11) have drastically
shifted from G1 to S phase. An increase in
thepopulationofapoptoticcells(17%)was
also observed in these cells. vopF mutant-
infectedcellscontainedanevenhigherpro-
portionofapoptoticcells(31%)andalmost
evenlydistributedpopulationsofG1,S,and
G2/Mcells.Apoptoticcellswerealsovisual-
ized using terminal deoxynucleotidyl-
transferase-mediated dUTP-biotin nick
end labeling (TUNEL) staining (see Fig. S4
in the supplemental material). The strain
harboring a deletion of all actin-
modulating domains of vopF (the VTV18
vopFDm2mutant)showedadistribution
similar to that of VTV18, suggesting that
theactinnucleationdomainofVopFisnot
involvedintheantiapoptoticactivityofthe
protein. Interestingly, replacing vopF with
vopN resulted in a distribution similar to
that of the type III mutant. These data sug-
gest that VopF and VopN are both capable
ofreducingthetypeIII-dependentapopto-
sis. Visualization of the infected cells sug-
gestedthatthecellsarrestedatSphasehave
an enlarged nucleus and cell size indicative of cell cycle arrest. The
accumulation of apoptotic cells instead of the restoration of normal
cell cycle distribution that resulted from infection with the vopF de-
letionmutantsuggeststhattheremaybeanunidentiﬁedcyclomodu-
lin responsible for the cell cycle arrest.
Role of VopE and VopF in epithelial integrity and diarrheal
response.Asinductionofcellcyclearrestbybacterialpathogenshas
FIG1 VopNisanactinnucleatorthatlocalizestotheactinstressﬁbers.(A)CHOcellsweretransfected
with vopF::pAcGFP-N1 or vopN::pAcGFP-N1 to express VopF-GFP or VopN-GFP fusion proteins,
respectively. Overlay images of Texas Red phalloidin (red) and VopF-GFP or VopN-GFP (green) are
shown. Bar  10 m. (B) Immunogold electron micrographs of vopF::gfp-o rvopN::gfp-transfected
CHO cells. The two right images are higher-magniﬁcation images of the boxed areas. Red arrows point
togoldlabeling.Bar2m(leftimages)or500nm(rightimages).(C)PyreneactinassayofVopFand
VopN.VopForVopNprotein(100,10,or1nM)wasincubatedwith2Mmonomericpyrene-labeled
actin. Actin polymerization was measured as arbitrary ﬂuorescence intensity (in arbitrary units [a.u.])
over time (seconds), with excitation and emission wavelengths of 365 and 407 nm, respectively. A
mixture of actin and pyrene actin, labeled as actin alone, served as a negative control.
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November/December 2010 Volume 1 Issue 5 e00289-10 mbio.asm.org 3FIG2 DomainanalysisofVopFandVopN.(A)TransfectionofhybridgenescomprisingvopFandvopNintoCHOcells.OverlayimagesofGFPfusionproteins
(green) and actin (red) are displayed. (B) Transfection of chimera genes comprising vopF and vopN into CHO cells. Overlay images of GFP fusion proteins
(green)andactin(red)aredisplayed.Micrographsontheleftarehigher-magniﬁcationimagesoftheboxedareas.Sinceallfourchimeragenes(vopFand-Nand
vopN and -F) showed the same phenotype, only the bottom set of chimera genes used to generate the ﬂuorescent micrographs is shown (asterisks). (C)
Transfection of VopF1-135-GFP and VopN1-85-GFP into CHO cells. Overlay images of nuclei (cyan), GFP fusion proteins (green), and actin (red) are displayed.
Bar  10 m.
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renewal and to prolong bacterial colonization through inhibition of
cellshedding(23),weinvestigatedtheroleofVopFandVopNinthe
context of our animal models. While we previously found that dele-
tionofvopFresultsina1.5-to2-logdefectinasucklingmousecom-
petition assay, vopN deletions in its native strains, 1587 and 1582
(another isolate from the same outbreak), surprisingly showed no
defect in colonization when these strains
competed with wild-type strains (Fig. 5A).
To understand whether actin nucleation
can complement a vopF deletion, we tested
theabilityofvopNtocomplementthevopF
deletion in AM-19226. Addition of vopN
into a vopF-deleted strain partially (1-log)
complemented vopF, suggesting that while
the actin nucleation activity of VopN and
VopF is important, it may not be sufﬁcient
to promote efﬁcient colonization in vivo
(Fig. 5A). While both vopN and vopF are
complemented by homologous recombi-
nation into the vopF locus, the level of ex-
pression and, more importantly, the trans-
location of VopF and VopN proteins may
differ,whichprovidesanalternateexplana-
tion for the phenotype. To understand the
role of VopF and VopN in pathogenesis,
they must be studied in the context of the
native strains because of their unique com-
bination of translocated effectors. Since a
VopNdeletionmutantof1587hasnophe-
notypic defect in colonization, probably
due to redundancy of the function of addi-
tional effectors, we focused on the role of
VopF in its native strain, AM-19226.
Since V. cholerae colonizes the single-
cell layer of the polarized small-intestinal
epithelium,wewantedtostudytheinterac-
tion of AM-19226 with host cells in the
more biologically relevant polarized-T84-
tissue-culture-cell model. After allowing
the T84 cells to differentiate in Transwell
inserts for 7 days, we infected the cells with
various bacterial strains and assessed the
changes in transepithelial resting potential
(Eo)andtransepithelialresistance(TER)to
determine the epithelial integrity.
In the polarized-T84-tissue-culture-cell
model, a decrease of TER in the absence of
increased Eo is indicative of the loosening
of tight junctions. T84 cells infected with
the wild-type strain VTV18 showed a 49%
decrease in resistance (Fig. 5B). Cells in-
fected with the type III structural mutant
(the vcsN2 mutant) were not affected
(3.4% increase), showing a level compara-
ble to that of the medium-alone control
(0.7% increase). These data suggested that
the decrease in TER is type III dependent.
For O1 V. cholerae-infected cells, a similar
decrease in TER is observed, which is de-
pendent on cholera toxin (data not shown) (24).
TheT3SSislandinAM-19226carriesanotherputativeeffector,
which we named vopE because of its homology to the T3SS effec-
toryopEfromYersiniaspecies.VopE,likeYopE,hasahighlycon-
servedGTPase-activatingprotein(GAP)domain.TheGAPactiv-
ity of YopE has been shown to inactivate RhoA, Rac1, and Cdc42
to depolymerize actin (25). VopE and VopF seem to have oppos-
FIG 3 VopF and VopN interact with distinct host proteins. (A) A yeast two-hybrid screen identiﬁed
ﬁlamin as the cellular interactor for VopN and PPIG, COMMD1, and BCA3 as the cellular interactors
for VopF. The Y184 Saccharomyces cerevisiae host strain carrying various preys fused to the Gal4 acti-
vation domain was mated with the AH109 strain carrying full-length vopF, the region encoding aa 1 to
135ofvopF,full-lengthvopN,ortheregionencodingaa1to84ofvopNfusedtotheGal4DNAbinding
domain. The resulting diploids were plated and restreaked onto SD–Ade–His–Leu–Trp–X--Gal to
select for colonies strongly expressing the Ade2, His3, and Mel1 reporters. (B) Immunoprecipitation
results between VopF1-135-GFP and VopN1-84-GFP for various preys fused to the pProLabel tag. The
presence of the prey proteins was assayed by chemiluminescence in the lysates (red) and anti-GFP-
immunoprecipitated fractions (blue). (C) Luciferase assays of 293T cells cotransfected with the NF-B
reporter and the indicated GFP vectors (250 ng) and stimulated with or without TNF- (100 ng/ml).
(D) Colocalization of ﬁlamin and various GFP fusion proteins. Various GFP fusion constructs were
transfected into CHO cells. Filamin was stained using antiﬁlamin antibodies. Overlay images of nuclei
(cyan), GFP fusion proteins (green), and ﬁlamin (red) are displayed. Bar  10 m.
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cleatesactin.However,apathogenpossessingeffectorswithseem-
ingly opposite functions has been observed previously in the
Salmonella T3SS, where SptP is a GAP and SopE is a GTPase-
exchangingfactor(GEF)(26).ThecombinationofSptPandSopE
helpsSalmonellatoinvadethehostcellsandsubsequentlyrecover
the actin cytoskeleton. Deleting vopE has a minimal effect on col-
onization in the infant mouse model (data not shown). To com-
pare the opposing functions of VopE and VopF in relation to
epithelial integrity, we tested single and double mutants in the
polarized-T84-cell system. Compared to the strongly decreased
TER caused by VTV18, the vopE and vopF deletion mutants
showed intermediate phenotypes (34.6% and 30.2%, respec-
tively). The vopF vopE double mutant (24.6%) showed a more
dramatic difference from VTV18. These data indicate that while
vopE and vopF are involved in loosening
of tight junctions, there are likely to be
additional effectors involved.
Tostudytheactincytoskeletalorganiza-
tion and disruption in cell polarity in in-
fectedcells,weﬁxedandstainedtheTrans-
wellinsertsforactin,ZO-1,andAM-19226
(11) (Fig. 2C). The medium-alone control
andvcsN2mutant-infectedcellsshoweda
normal localization of ZO-1, a tight-
junctionprotein.Thex-zandy-zplanemi-
crographsdepictedthatZO-1waslocalized
to the apical surfaces of the polarized cells.
A normal cortical actin network at the api-
calsurfaceandtheperijunctionalactinring
was also observed. Cells infected with
VTV18 showed massive depolymerization
of actin, where minimal cortical actin was
observedalongwithredistributionofZO-1
toward the basolateral surface, consistent
with loss of cell polarity and intercellular
tight junctions. vopF and vopE mutant-
infected cells also showed a certain degree
of depolarization based on ZO-1 mislocal-
izationbutnoticeablymore-abundantcor-
tical actin than wild-type-infected cells. In
contrast, cells infected with the vopEF
mutant maintained the tight junction and
cell polarity relatively well, showing some-
whatnormaldistributionofZO-1andactin
in large areas throughout the monolayer.
Overall, these results are fully consistent
with our functional measurement of epi-
thelial barrier function as assessed by TER.
Disruption of tight-junction integrity
has been identiﬁed as the common mecha-
nism for diarrhea in gastrointestinal dis-
easessuchasulcerativecolitis(27),Crohn’s
disease (28), and gastritis caused by bacte-
rial pathogens (29, 30). To correlate the re-
sults from the electrophysiology experi-
ment with those from an in vivo model, we
employed the removable intestinal tie-
adult rabbit diarrhea (RITARD) assay to
study the diarrheal response (Fig. 5D). Out
of10animalsinfectedwithwild-typeAM-19226,9hadfataldiarrhea
and1hadnonfataldiarrhea.vcsN2mutant-infectedanimalshadno
symptoms (10/10). The vopF mutant, the vopE mutant, and the
double mutants all had intermediate phenotypes, ranging from fatal
andnonfataldiarrheatonosymptoms.Thesedataconcurwiththein
vitro electrophysiology data indicating that vopE and vopF together
strongly contribute to the disruption of tight junctions and diarrhea
in infected animals.
DISCUSSION
V. cholerae is a Gram-negative bacterium that colonizes the small
intestine and causes a massive diarrheal response. In the pandemic
O1 and O139 strains, the toxin-coregulated pilus (TCP) is the major
virulence factor that contributes to the colonization of the intestinal
epithelium.Aftercolonizingandreplicatinginthesmallintestine,the
FIG4 Cellcycleanalysis.HeLacellswereinfectedwithV.choleraeatanMOIof100for4h.Cellswere
then incubated in gentamicin for 72 h before being ﬁxed in 75% ethanol and stained with propidium
iodide. Cells were analyzed by ﬂow cytometry. Cells were also stained for actin (red) and nuclei (cyan)
for microscopy analysis. Bar  50 m.
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cellsinanAB5toxin-dependentmanner.TheO1andO139virulence
mechanisms seem modular, requiring two separate proteins; how-
ever, the results from this study suggest that colonization and diar-
rheal induction are interconnected in T3SS non-O1, non-O139
strains, with a single protein contributing to both processes.
Previously, we described a type III effector, VopF, which is an
actin nucleator that induces protrusion formation in transfected
or infected cells and is required for efﬁ-
cient colonization in the infant mouse
model. In this study, we have identiﬁed a
divergent T3SS pathogenicity island in
additional non-O1, non-O139 strains,
1587 and 623-39, which were sequenced
as part of the NIAID microbial sequenc-
ing project. This T3SS island encodes a
VopF homolog, VopN. We have shown
that VopN is an actin nucleator like
VopF, but unlike VopF, it localizes to
stress ﬁber, similarly to VopL from
V. parahaemolyticus.
Chimeraandtransfectionstudiessug-
gested that the amino-terminal portions
of the proteins, preceding the FH1-like
domain, are responsible for the differing
localizations of the proteins in host cells.
A yeast two-hybrid study identiﬁed ﬁl-
aminastheinteractingpartnerforVopN.
Filaminisahigh-molecular-weightactin-
cross-linking protein that localizes to
stress ﬁbers in cultured cells. In addition
to organizing actin ﬁlaments into bun-
dled networks, ﬁlamins may also be re-
quired for formation of ﬁlopodia. Addi-
tionally, ﬁlamin acts as a scaffolding
proteinforsignalingproteinsandbridges
transmembrane proteins to the actin cy-
toskeleton. Interestingly, the Salmonella
typeIIIeffectorsSsph2andSselhavebeen
shown to bind ﬁlamin and inhibit actin
polymerization to avoid vacuole-
associated actin polymerization (31). As
bacterial pathogens have evolved numer-
ous mechanisms to manipulate the actin
cytoskeleton, ﬁlamin may be a suitable
target for localizing effector proteins and
modulating actin dynamics. By studying
the interactions of host proteins and
VopF, we discovered that AM-19226 af-
fects the cell cycle progression of infected
cells and that the presence of vopF pre-
vents apoptosis. While the mechanism
remainstobeelucidated,actinnucleation
and polymerization activity of VopF are
not required for the antiapoptotic activ-
ity. Numerous bacterial effectors, such as
cytolethal distending toxin (CDT) and
cycle-inhibiting factor (Cif) (23), have
been shown to affect the eukaryotic cell
cycle. Arresting the cell cycle has been
proposed to beneﬁt pathogens infecting the intestinal epithelium
(23), which normally undergoes a high rate of cell turnover, with
a cellular life span of less than 5 days in humans.
The newly identiﬁed VopN protein provided a tool for dissecting
the actin nucleation function away from the cellular phenotype in-
duced by the bacterial effectors. By complementing a vopF deletion
with vopN, we determined that vopN can only partially complement
thedefect.Surprisingly,deletionofvopNin1587or1582hadamin-
FIG 5 Assay for pathogenicity in rabbits. (A) Competitive index results from the infant mouse
colonization model. AMD, 1587, and 1582 show the AM-19226, 1587, and 1582 strains of V. cholerae,
respectively. The competitive index was calculated as the ratio of the output of the test strain to the
output of the reference strain over the ratio of the input of the test strain to the input of the reference
strain. An asterisk denotes that the differences between the populations are statistically signiﬁcant as
determined by the Mann-Whitney U test (P  0.05). (B) Percent decrease in TER after infection with
V. cholerae. VTV18, a endo rtx hly hap mutant of AM-19226, was used as the wild-type strain.
Values were derived by dividing the difference between the recorded resistance observed at the begin-
ning and that observed at the end of the 180-min period by the initial resistance value. An asterisk
denotes that the differences between the populations are statistically signiﬁcant as determined by the
Mann-Whitney U test (P  0.05). (C) Confocal micrographs of T84 cells infected with V. cholerae
strains. Overlay images of bacteria (cyan), actin (green), and ZO-1 (red) are shown. The top panel of
each micrograph displays a cross section of the x-z plane (apical toward the top and basolateral toward
thebottom),andtheleftpaneldisplaysacrosssectionofthey-zplane,whilethemainpaneldisplaysthe
x-y view onward to the apical side. (D) Diarrheal response of adult rabbits in the RITARD model.
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defect in colonization may be explained by the presence of a gene
encodingaputativecytotoxicnecrotizingfactor(CNF).CNFbelongs
to a family of Rho GTPase-activating proteins, which includes der-
monecrotic toxin (DNT) from Bordetella, SopE/SopE2 from Salmo-
nella, IpgB1/2 from Shigella, and Map from enteropathogenic Esche-
richia coli (EPEC)/enterohemorrhagic E. coli (EHEC) (32, 33). CNF
from E. coli has been shown to affect tight junctions (34) and forms
ﬁlopodia and stress ﬁbers (35). The presence of CNF may be func-
tionallyredundanttoVopNorVopFeventhoughCNFisfoundonly
in the 1587 T3SS and V. parahaemolyticus T3SS2 pathogenicity is-
lands. Interestingly, CNF is also a cyclomodulin that induces
multinucleation (23) and prevents apoptosis by remodeling the mi-
tochondrial network (36). Although CNF is not present in the AM-
19226T3SSpathogenicityisland,atypeIIIeffectornamedVopEwas
identiﬁed. VopE is a homolog of YopE from Yersinia. Similar to
YopE, VopE has a putative GTPase-activating protein domain. By
inactivating RhoA, Rac1, and Cdc42, YopE depolymerizes actin and
inhibits phagocytosis by macrophages and other immune cells (25,
37).YopEhasalsobeenshowntodepolarizetheepitheliallayer(38).
Since V. cholerae colonizes the small intestine, which is lined with a
single layer of polarized cells, we investigated how AM-19226 would
interact with a polarized-T84-cell model. As the TER and confocal
micrographs showed, AM-19226 translocates VopE and VopF to re-
organize the actin cytoskeleton and depolarize the epithelium. Loos-
ening the tight junctions has been a common strategy by which bac-
terial pathogens cause diarrhea in the human host. We investigated
the diarrheal response to AM-19226 in the adult rabbit model and
determined that the T3SS is required for causation of diarrhea; vopE
and vopF both contribute to this phenotype.
WiththediscoveryoftheT3SSinV.choleraeanditsroleinthe
virulence of non-O1, non-O139 strains, it is astonishing to ob-
servehowthisbacteriumhasevolvedtwoindependentpathogenic
mechanisms to cause similar diseases. The presence of a homolo-
gous T3SS pathogenicity island in other non-O1, non-O139
V. cholerae strains and an orthologous T3SS2 island in the se-
quenced pandemic V. parahaemolyticus strain conﬁrms that the
T3SShasemergedtobeaviableconservedpathogenicmechanism
among Vibrio species. The genetic events and mechanisms in
whichvirulentstrainsgaintheabilitytocauseepidemicsandpan-
demics have yet to be elucidated, and further investigation of
T3SS-dependent cholera-like gastroenteritis will help us combat
the disease caused by a rapidly evolving and diverse pathogen.
MATERIALS AND METHODS
Cell lines and bacterial strains. Chinese hamster ovary (CHO) cells
(ATCC ccl-61) were cultivated in Ham’s F-12K medium supplemented
with 10% fetal calf serum (FCS) and L-glutamine (2 mM) adjusted to
contain 1.5 g/liter sodium bicarbonate. HeLa, HEK293, and 293T cells
werecultivatedinDulbecco’smodiﬁedEagle’smedium(DMEM)supple-
mented with 10% fetal bovine serum (FBS) and L-glutamine (2 mM).
V. cholerae AM-19226, 1587, and 1582, non-O1, non-O139 strains of
serogroupO39,O12strains,andN16961,anO1ElTorbiotype,wereused
in this study. E. coli and V. cholerae strains were propagated in LB con-
taining appropriate antibiotics at 37°C.
Strain construction. Deletion mutations were constructed by in-
frame deletions of the entire reading frame using a technique described
previously (39). vopF and vopN genes were complemented into the ge-
nome at the vopF locus using homologous recombination.
Protein expression and puriﬁcation. vopF and vopN genes were
cloned into pET28a (EMD Biosciences), which introduces an N-terminal
fusionoftheproteintoaHis6tag.BL21(DE3)strainscarryingexpression
plasmids were subcultured 1:1,000 into 1 liter of 2 yeast extract-
tryptone (YT) medium growing at 37°C with aeration until the optical
density at 600 nm reached 0.5 and were induced using 0.8 mM IPTG
(isopropyl--D-thiogalactopyranoside) and incubated at 18°C overnight.
Cells were harvested and suspended in 500 mM NaCl, 50 mM Tris
(pH7.5),10%glycerol,15mMimidazole,2mM-mercaptoethanoland
lysed by lysozyme and sonication. The fusion protein was puriﬁed by
afﬁnity chromatography using His-Trap HP (GE Health Systems).
Pyrene actin assay. The pyrene actin assay was described previously
(40). Rabbit skeletal muscle actin was puriﬁed as described previously
(41). Protein samples were dialyzed using Slide-a-lyzer (Pierce) in assay
bufferfor2h,and100nMofVopForVopNproteinwasusedintheassays
unless speciﬁed.
Eukaryotic cell transfection. vopF and vopN and various chimera
geneswereclonedintopAcGFP-N1(Clontech)tomaketransfectionvec-
tors expressing GFP fusion proteins. pAcGFP-N1, which encodes a GFP
from Aequorea coerulescens, was also used as a positive control for trans-
fection.PlasmidDNAwasextractedusinganendotoxin-freemaxiprepkit
(Qiagen).
CHO cells were seeded onto 18-mm glass coverslips (no. 1.5). jetPEI
(polyPlus) transfection reagent was used as recommended by the manu-
facturer. At 24 h posttransfection, cells were ﬁxed with 3.7% formalde-
hyde and permeabilized with 0.1% Triton X-100. Actin ﬁlaments were
stained with Alexa Fluor 568-conjugated phalloidin (Invitrogen). The
slides were then covered with coverslips and observed with a Nikon in-
verted ﬂuorescence microscope.
Immunogold electron microscopy. CHO cells were seeded and trans-
fected as described above. At 24 h posttransfection, cells were permeabilized
with 0.1% Triton X-100 and ﬁxed in 4% paraformaldehyde-0.025% gluter-
aldehyde. After being blocked with 1% ﬁsh gelatin, cells were stained with
mouse monoclonal anti-GFP antibodies (1:50 dilution) (JL-8; Clontech) for
1 h and then incubated with a bridging rabbit anti-mouse antibody (1:65
dilution) for 30 min. Lastly, colloidal gold (10 nm)-conjugated secondary
antibodieswereincubatedwiththesamplesfor1h.Asecondaryﬁxationwas
performedwith3%gluteraldehyde.Sampleswerepostﬁxedwith1%osmium
and stained with 1% aqueous uranyl acetate. After dehydration, a propylene
oxide-epon araldite mixture was used to inﬁltrate the samples, which were
mountedandsectioned.MicroscopywasperformedusingaTecnaiG2Spirit
BioTWIN,andimageswerecapturedwithanAMT2kcharge-coupled-device
(CCD) camera.
Yeasttwo-hybridscreen.vopFandvopNgeneswereclonedintopGBT9
(Clontech) and transformed into AH109 strains. The bait strains were
screened against a pretransformed human HeLa matchmaker cDNA library
(Clontech) on synthetic deﬁned (SD)/Ade/His/Trp/Leu/X--Gal
(5-bromo-4-chloro-3-indolyl alpha-D-galactopyranoside) agar plates. Blue
colonies were restreaked multiple times to conﬁrm the phenotype. Plasmids
wererescuedfromSaccharomycescerevisiaeandtransformedintoE.coliKC8
cells.PuriﬁedDNAwasreintroducedintoyeastcellstoconﬁrminteractions.
Coimmunoprecipitation. Genes encoding the VopF/VopN-interacting
proteins were cloned into the pProLabel-C vector using InFusion cloning
(Clontech). HEK293 cells were cotransfected with vopF1-135::pAcGFP or
vopN1-84::pAcGFP constructs and various prey fusion constructs. At 36 h
posttransfection, cells were lysed using M-PER mammalian protein extrac-
tion reagent (Thermo Scientiﬁc) in the presence of protease inhibitors
(Roche). GFP fusion proteins were immunoprecipitated using polyclonal
anti-GFPantibodies(Clontech)withproteinADynabeads(Invitrogen).Pro-
LabelfusionproteinwasdetectedusingachemiluminescenceProLabelassay
(Clontech). The ﬂuorescence and chemiluminescence of the cell lysates and
immunoprecipitated fractions were determined using an Envision3 plate
reader (PerkinElmer).
Luciferase assay. Luciferase assays were performed using the dual-
luciferase reporter assay system (Promega) according to the manufactur-
er’s instructions. The levels of the ﬁreﬂy luciferase activities were mea-
sured and normalized to the activity of phRL-TK-derived Renilla
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from triplicate experiments.
Cell cycle analysis and TUNEL staining. The cell cycle distribution
and apoptotic population of HeLa cells were determined as previously
described(42,43).Brieﬂy,~5108HeLacellswereinfectedwithV.chol-
erae strains at a multiplicity of infection (MOI) of 100 for 4 h. Cells were
washed with phosphate-buffered saline (PBS) and incubated in medium
with 100 g/ml gentamicin for 72 h. Cells were then washed, trypsinized,
ﬁxedin75%ethanol,andstainedinapropidiumiodide-RNaseAsolution
(Invitrogen). Flow cytometric analysis was performed with a FACSCali-
bur ﬂow cytometer (Becton Dickinson) using the PI emission (630 nm)
forDNAquantiﬁcation.Datafrom104cellswerecollectedandanalyzed
using CELLQUEST software (Becton Dickinson). Apoptotic cells were
stained using an APO-BrdU TUNEL assay kit (Invitrogen).
Polarized-T84-epithelial-cell infection. Electrophysiology experiments
werecarriedoutaspreviouslydescribed(24).Brieﬂy,T84cellswerecultured
in 0.33-cm2Transwell inserts in T84 medium. Experiments were performed
10 to 12 days after the plating. Cells were rinsed in Hanks’ balanced salt
solution and were transferred into CO2-independent medium with 1% se-
rum.Transwellinsertswerekeptat37°CwithoutCO2onaplatewarmerorin
anincubatorforthecourseoftheexperiments.IscandTERweremeasuredat
10-min intervals using a dual voltage clamp device. V. cholerae strains were
subcultured to log phase in LB at 37°C, washed, and diluted to 109 CFU per
ml.Inallexperiments,10lofbacteriawaspipettedintotheapicalchamber
of the Transwell insert. After the electrophysiology experiment, cells were
ﬁxedusing3.7%formaldehydeandpermeabilizedusing0.1%TritonX-100.
Rabbitanti-AM-19226antibodies,mouseanti-ZO-1antibodies(Zymogen),
and Alexa Fluor 568-conjugated goat anti-rabbit antibodies (Invitrogen)
were used to visualize the bacteria or VopF protein. Alexa Fluor 633-
conjugatedphalloidin(Invitrogen)wasusedtostaintheactin.Theslideswere
thencoveredwithcoverslipsandobservedonaNikonspinning-diskconfocal
microscope.
Infant mouse colonization. The infant mouse colonization assay was
described previously (44). V. cholerae bacteria (1  106) were inoculated
intragastrically into 5-day-old CD-1 mice (Charles River Laboratories).
Infectedpupswerekilledafter20h,andintestinalcolonizedbacteriawere
quantiﬁed as described previously (44). A competition assay was per-
formed by coinoculation with the lacZ wild-type AM-19226, 1587, or
1582 strain. Differentiation of wild-type or mutant strains was based on
blue/whitecoloniesonLBplatescontainingX-Gal(5-bromo-4-chloro-3-
indolyl--D-galactopyranoside). The competitive index was calculated as
the ratio of the number of CFU of the test strain to the number of CFU of
the reference strain divided by the ratio of the size of the inoculum of the
test strain to the size of the inoculum of the reference strain. If no CFU
were recovered from the intestine, a colony value of 1 was assigned to the
lowest dilution.
Rabbit diarrheal assay. Diarrheal response of rabbits to V. cholerae
was assayed by the removable intestinal tie-adult rabbit diarrhea (RI-
TARD) model, using adult New Zealand White rabbits weighing 1.5 to
2.7 kg (45). After inoculation, rabbits were observed at 6-h intervals for
7 days for death, diarrheal severity, and shedding of challenge organisms.
All rabbits that died were subjected to postmortem examination to assess
the amount of ﬂuid in the intestine.
Ethics statement. The animal experiments were performed with pro-
tocols approved by the Harvard Medical School Ofﬁce for Research Pro-
tection Standing Committee on Animals. This committee approved the
animal protocol used in this study. The Harvard Medical School animal
managementprogramisaccreditedbytheAssociationfortheAssessment
and Accreditation of Laboratory Animal Care, International (AAALAC),
andmeetsNationalInstitutesofHealthstandardsassetforthintheGuide
fortheCareandUseofLaboratoryAnimals(DHHS[NIH]publicationno.
85-23, revised 1996). The institution also accepts as mandatory the PHS
Policy on Humane Care and Use of Laboratory Animals by Awardee In-
stitutions and NIH Principles for the Utilization and Care of Vertebrate
AnimalsUsedinTesting,Research,andTraining.Thereisonﬁlewiththe
Ofﬁce of Laboratory Animal Welfare (OLAW) an approved Assurance of
Compliance (A3431-01).
Sequence and comparative genomic analysis. The BLAST-Extend-
Repraze (BER) algorithm and BLAST searches were used to compare nu-
cleic acid and amino acid sequence homologies (46, 47). Artemis version
8 from the Sanger Institute was used to visualize and annotate sequence
data (48). ACT from the Sanger Institute was used to visualize BLASTn
and tBLASTx comparisons (49).
Statistical analysis. The paired differences of experimental groups
werecomparedusingthenonparametricMann-WhitneyUtest.APvalue
of 0.05 was considered statistically signiﬁcant.
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